LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 864

Search options

  1. Article ; Online: Global Rounds: Poland.

    Sokolska, Justyna M / Ponikowski, Piotr

    Circulation

    2024  Volume 149, Issue 3, Page(s) 174–176

    MeSH term(s) Humans ; Poland/epidemiology ; Cardiovascular Diseases ; Risk Factors
    Language English
    Publishing date 2024-01-16
    Publishing country United States
    Document type Journal Article
    ZDB-ID 80099-5
    ISSN 1524-4539 ; 0009-7322 ; 0069-4193 ; 0065-8499
    ISSN (online) 1524-4539
    ISSN 0009-7322 ; 0069-4193 ; 0065-8499
    DOI 10.1161/CIRCULATIONAHA.123.063673
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Book: Przewlekła niewydolność krążenia rozpoznawanie i leczenie

    Ponikowski, Piotr

    standardy postępowania ; task force report

    (Kardiologia polska ; [58,2, Suppl.] ; Biblioteka "Kardiologii Polskiej")

    2003  

    Title variant Niewydolność serca
    Institution European Society of Cardiology
    Author's details European Society of Cardiology. Komentarz Piotr Ponikowski
    Series title Kardiologia polska ; [58,2, Suppl.]
    Biblioteka "Kardiologii Polskiej"
    Collection
    Language Polish
    Size 101 S. : graph. Darst.
    Publishing place Warszawa
    Publishing country Poland
    Document type Book
    HBZ-ID HT013634672
    Database Catalogue ZB MED Medicine, Health

    Kategorien

  3. Article ; Online: Iron Deficiency in Heart Failure: A Korea-Oriented Review.

    Jankowska, Ewa A / Ponikowski, Piotr

    International journal of heart failure

    2023  Volume 5, Issue 4, Page(s) 173–183

    Abstract: Iron deficiency (ID) occurs at high frequency across the spectrum of heart failure (HF), with HF severity and race being potentially important predictors for its development. ID, irrespective of anaemia status, leads to poor outcomes in patients with HF, ...

    Abstract Iron deficiency (ID) occurs at high frequency across the spectrum of heart failure (HF), with HF severity and race being potentially important predictors for its development. ID, irrespective of anaemia status, leads to poor outcomes in patients with HF, including exacerbated reduction in exercise capacity, poor quality of life (QoL) and increased risk of HF hospitalisation. As ID has a large public health and economic burden in Asia, and patients hospitalised with acute HF in the Asia Pacific vs. other regions commonly present with more severe clinical symptoms, there is a clear need to identify and treat ID promptly in Asian patients with HF. The biomarkers serum ferritin and transferrin saturation are used for ID diagnosis, and periodic screening is recommended in all patients with HF. The intravenous iron treatments, ferric carboxymaltose (FCM) and ferric derisomaltose, have demonstrated efficacy and tolerability in patients with acute or chronic HF and ID, with FCM shown to be cost-effective (and in some cases cost-saving). Meta-analyses support the likely benefits of intravenous FCM for improving QoL and reducing HF hospitalisation, without reducing mortality risk in patients with HF and ID. Accordingly, European Society of Cardiology guidelines recommend considering intravenous FCM for patients with symptomatic HF with left ventricular ejection fraction ≤50% who were recently hospitalised for HF and have ID. Although analyses of Asian patients with HF and ID are limited, the effects of intravenous iron would be expected to be similar to that in White populations; further clarifying studies may be of interest.
    Language English
    Publishing date 2023-10-25
    Publishing country Korea (South)
    Document type Journal Article ; Review
    ISSN 2636-1558
    ISSN (online) 2636-1558
    DOI 10.36628/ijhf.2023.0032
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Acyl-ghrelin therapy for heart failure: already a novel inotrope or even more?

    Jankowska, Ewa A / Ponikowski, Piotr

    European heart journal

    2023  Volume 44, Issue 22, Page(s) 2026–2028

    MeSH term(s) Humans ; Ghrelin/metabolism ; Calcium ; Myocytes, Cardiac/metabolism ; Heart Failure/physiopathology
    Chemical Substances acyl-ghrelin ; Ghrelin ; Calcium (SY7Q814VUP)
    Language English
    Publishing date 2023-06-09
    Publishing country England
    Document type Editorial ; Comment
    ZDB-ID 603098-1
    ISSN 1522-9645 ; 0195-668X
    ISSN (online) 1522-9645
    ISSN 0195-668X
    DOI 10.1093/eurheartj/ehad220
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Striving for the 'perfect' definition of iron deficiency in heart failure.

    Biegus, Jan / Ponikowski, Piotr

    European journal of heart failure

    2023  Volume 25, Issue 11, Page(s) 2075–2077

    MeSH term(s) Humans ; Heart Failure/diagnosis ; Iron Deficiencies ; Iron ; Anemia, Iron-Deficiency/diagnosis
    Chemical Substances Iron (E1UOL152H7)
    Language English
    Publishing date 2023-10-12
    Publishing country England
    Document type Editorial ; Comment
    ZDB-ID 1483672-5
    ISSN 1879-0844 ; 1388-9842
    ISSN (online) 1879-0844
    ISSN 1388-9842
    DOI 10.1002/ejhf.3051
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Empagliflozin in patients hospitalized for acute heart failure.

    Ponikowski, Piotr / Biegus, Jan

    European heart journal

    2022  Volume 43, Issue 41, Page(s) 4219–4221

    MeSH term(s) Humans ; Glucosides/therapeutic use ; Benzhydryl Compounds/therapeutic use ; Heart Failure/drug therapy ; Stroke Volume ; Diabetes Mellitus, Type 2
    Chemical Substances empagliflozin (HDC1R2M35U) ; Glucosides ; Benzhydryl Compounds
    Language English
    Publishing date 2022-08-08
    Publishing country England
    Document type Journal Article
    ZDB-ID 603098-1
    ISSN 1522-9645 ; 0195-668X
    ISSN (online) 1522-9645
    ISSN 0195-668X
    DOI 10.1093/eurheartj/ehac427
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Prevalence of increased intra-abdominal pressure and its impact on renal function in acute decompensated heart failure: A prospective pilot study.

    Łagosz, Piotr / Biegus, Jan / Lewandowski, Łukasz / Ponikowski, Piotr / Zymliński, Robert

    Kardiologia polska

    2024  Volume 82, Issue 3, Page(s) 292–302

    Abstract: Background: Intra-abdominal pressure (IAP) is a frequently overlooked aspect in clinical assessment that can have a significant impact on organ dysfunction in patients with acute decompensated heart failure (ADHF).: Aims: We aimed to investigate ... ...

    Abstract Background: Intra-abdominal pressure (IAP) is a frequently overlooked aspect in clinical assessment that can have a significant impact on organ dysfunction in patients with acute decompensated heart failure (ADHF).
    Aims: We aimed to investigate dynamics of IAP in patients with ADHF and its impact on diuretic response.
    Methods: We conducted a prospective observational pilot study on a group consisting of 30 patients admitted for ADHF. In every individual IAP measurement, blood and urine samples were taken upon admission, on the second and third days of hospitalization.
    Results: The study showed a high (63.3%) prevalence of intra-abdominal hypertension (IAH) defined as IAP ≥12 mm Hg upon admission, while only roughly 13% had signs of ascites. We observed poorer diuresis on the first day of hospitalization in the IAH group (P = 0.03). IAP was negatively correlated with urine output (P = 0.01) and positively correlated with urine osmolality (P = 0.03) on the first day of hospitalization. During follow-up, there was a significant decrease in IAP in patients with IAH upon admission who received standard decongestive therapy.
    Conclusions: The study shows a high prevalence of IAH in patients admitted for ADHF, even in individuals who do not present symptoms of abdominal congestion. Established correlation between IAP, reduced diuresis, and increased urine osmolality, despite achieving target natriuresis, contributes novel insights into the understanding of pathomechanisms underlying diuretic resistance in ADHF.
    MeSH term(s) Humans ; Pilot Projects ; Prospective Studies ; Prevalence ; Heart Failure/epidemiology ; Intra-Abdominal Hypertension/epidemiology ; Intra-Abdominal Hypertension/diagnosis ; Diuretics/therapeutic use ; Kidney
    Chemical Substances Diuretics
    Language English
    Publishing date 2024-03-17
    Publishing country Poland
    Document type Observational Study ; Journal Article
    ZDB-ID 411492-9
    ISSN 1897-4279 ; 0022-9032
    ISSN (online) 1897-4279
    ISSN 0022-9032
    DOI 10.33963/v.phj.99497
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Estimated population-level benefits of sodium-glucose cotransporter-2 inhibitors introduction in the Polish population.

    Iwanek, Gracjan / Zymliński, Robert / Ponikowski, Piotr / Biegus, Jan

    Polish archives of internal medicine

    2023  Volume 133, Issue 7-8

    MeSH term(s) Humans ; Sodium-Glucose Transporter 2 Inhibitors/therapeutic use ; Diabetes Mellitus, Type 2/drug therapy ; Poland ; Glucose ; Sodium
    Chemical Substances Sodium-Glucose Transporter 2 Inhibitors ; Glucose (IY9XDZ35W2) ; Sodium (9NEZ333N27)
    Language English
    Publishing date 2023-07-04
    Publishing country Poland
    Document type Journal Article
    ZDB-ID 123500-x
    ISSN 1897-9483 ; 0032-3772
    ISSN (online) 1897-9483
    ISSN 0032-3772
    DOI 10.20452/pamw.16524
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Pathophysiology and Treatment Opportunities of Iron Deficiency in Heart Failure: Is There a Need for Further Trials?

    Tkaczyszyn, Michał / Fudim, Marat / Ponikowski, Piotr / Biegus, Jan

    Current heart failure reports

    2023  Volume 20, Issue 4, Page(s) 300–307

    Abstract: Purpose of review: Iron deficiency (ID) complicates heart failure (HF) at different stages of the natural history of the disease; however, this frequent comorbidity is still not comprehensively understood and investigated in terms of pathophysiology. ... ...

    Abstract Purpose of review: Iron deficiency (ID) complicates heart failure (HF) at different stages of the natural history of the disease; however, this frequent comorbidity is still not comprehensively understood and investigated in terms of pathophysiology. Intravenous iron therapy with ferric carboxymaltose (FCM) should be considered to improve the quality of life, exercise capacity, and symptoms in stable HF with ID, as well as to reduce HF hospitalizations in iron-deficient patients stabilized after an episode of acute HF. The therapy with intravenous iron, however, continues to generate important clinical questions for cardiologists.
    Recent findings: In the current paper, we discuss the class effect concept for intravenous iron formulations beyond FCM, based on the experiences of nephrologists who administer different intravenous iron formulations in advanced chronic kidney disease complicated with ID and anemia. Furthermore, we discuss the neutral effects of oral iron therapy in patients with HF, because there are still some reasons to further explore this route of supplementation. The different definitions of ID applied in HF studies and new doubts regarding possible interactions of intravenous iron with sodium-glucose co-transporter type 2 inhibitors are also emphasized. The experiences of other medical specializations may provide new information on how to optimally replenish iron in patients with HF and ID.
    MeSH term(s) Humans ; Anemia, Iron-Deficiency/drug therapy ; Anemia, Iron-Deficiency/etiology ; Anemia, Iron-Deficiency/diagnosis ; Quality of Life ; Heart Failure/complications ; Heart Failure/drug therapy ; Iron Deficiencies ; Iron/therapeutic use
    Chemical Substances ferric carboxymaltose (6897GXD6OE) ; Iron (E1UOL152H7)
    Language English
    Publishing date 2023-07-10
    Publishing country United States
    Document type Journal Article ; Review ; Research Support, Non-U.S. Gov't
    ZDB-ID 2151202-4
    ISSN 1546-9549 ; 1546-9530
    ISSN (online) 1546-9549
    ISSN 1546-9530
    DOI 10.1007/s11897-023-00611-3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Targeting Iron Deficiency in Heart Failure: Existing Evidence and Future Expectations.

    Ponikowski, Piotr / Jankowska, Ewa A

    Circulation. Heart failure

    2021  Volume 14, Issue 5, Page(s) e008299

    MeSH term(s) Anemia, Iron-Deficiency/diagnosis ; Anemia, Iron-Deficiency/drug therapy ; Ferritins ; Heart Failure/diagnosis ; Heart Failure/therapy ; Hemoglobins/metabolism ; Humans ; Motivation
    Chemical Substances Hemoglobins ; Ferritins (9007-73-2)
    Language English
    Publishing date 2021-05-18
    Publishing country United States
    Document type Editorial ; Comment
    ZDB-ID 2429459-7
    ISSN 1941-3297 ; 1941-3289
    ISSN (online) 1941-3297
    ISSN 1941-3289
    DOI 10.1161/CIRCHEARTFAILURE.121.008299
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top